#Eli Lilly

14 Oct 2026

Roche Agrees to $100 Million Deal for Obesity Drug Targeting Fat Cells

The Swiss drugmaker signed an agreement to license a molecule from Rona Therapeutics that uses RNA interference to affect metabolic targets.

Read more